Protagonist Therapeutics, Inc. (PTGX) Earnings
NASDAQ·Healthcare·Biotechnology
$148.10
+2.02%
Mkt Cap $9.37B
EPS — Estimate vs Actual
Mkt Cap
$9.37B
P/E
—
Fwd P/E
26.94
P/S
529.61
Rev TTM
—
EPS TTM
-$1.81
NASDAQ·Healthcare·Biotechnology
$148.10
+2.02%
Mkt Cap $9.37B
Mkt Cap
$9.37B
P/E
—
Fwd P/E
26.94
P/S
529.61
Rev TTM
—
EPS TTM
-$1.81